Artificial Intelligence (AI) is no longer a distant concept for the future—it is here, actively reshaping healthcare as we know it. From streamlining administrative burdens to enhancing clinical decision-making, AI is poised to be the most transformative force in modern medicine. However, the rapid evolution of AI demands structured, responsible implementation to ensure it serves its ultimate purpose: improving patient outcomes while safeguarding providers and health systems.

Two organizations at the forefront of this mission—the Center for Telehealth and e-Health Law (CTeL) and the Coalition for Health AI (CHAI)—have been working to bridge the gap between AI’s potential and its responsible deployment. Their insights into AI governance, transparency, workforce training, and liability protections form a crucial roadmap for policymakers, health systems, and digital health innovators navigating this evolving landscape.

As the Drug Enforcement Administration (DEA) approaches a critical decision on telehealth prescribing waivers at the end of 2025, groundbreaking research sponsored by the Center for Telehealth & e-Health Law (CTeL) in collaboration with Charm Economics provides compelling evidence that expanded telehealth access does not contribute to increased drug diversion. Contrary to long-standing concerns, this study indicates that telehealth expansion—supported through payment parity laws—may actually reduce overdose rates by improving access to treatment for opioid use disorder (OUD) and other substance use disorders (SUDs).

We commend Congress for extending telehealth flexibilities in the recent Continuing Resolution (CR), a crucial step in maintaining patient access and care continuity. Allowing these waivers to expire could significantly disrupt healthcare services, particularly for Medicare beneficiaries. Notably, during the COVID-19 pandemic, telehealth usage among Medicare beneficiaries surged from 1% in 2019 to 44% in 2020, highlighting its critical role in healthcare delivery (Bipartisan Policy Center, 2022).

The Center for Telehealth and e-Health Law (CTeL) continues to be a leading voice in shaping policies that impact digital health, telemedicine, and artificial intelligence in healthcare. Through our collaborative efforts, we have provided comprehensive responses to key regulatory proposals, ensuring that the interests of patients, providers, and healthcare innovators are well-represented. Our recent comment letters on the Drug Enforcement Administration’s (DEA) Special Registration Rule and the Administration’s AI Action Plan highlight the critical role CTeL plays in advancing legislation that supports the future of digital healthcare.

On March 12, the Center for Telehealth and e-Health Law (CTeL) brought the future of healthcare straight to Capitol Hill. Nearly 30 vendors participated in CTeL’s Digital Health Tech and AI Showcase, presenting groundbreaking innovations to congressional staffers and emphasizing the urgent need for regulatory support to advance digital health and artificial intelligence (AI) in medicine. The event also honored key figures driving change, including Congresswoman Doris Matsui and Dr. Andrew Taylor, highlighting the growing support for responsible AI in healthcare.

March 11, 2025 marks the five-year anniversary of the declaration of the COVID-19 pandemic. The COVID-19 pandemic, declared by the World Health Organization in March 2020, radically reshaped the healthcare landscape, accelerating the adoption of telehealth and digital health services. As we mark the five-year anniversary of the pandemic's declaration, it is critical to reflect on how telehealth has evolved, how policy and legislation have supported its growth, and the instrumental role that CTeL has played in shaping telehealth policy and guidance.=

The March 2025 Continuing Resolution (CR) includes significant extensions for telehealth flexibilities and reimbursement policies that were set to expire on March 31, 2025. These extensions push the expiration date to September 30, 2025, providing a six-month reprieve for healthcare providers, hospitals, and patients who rely on telehealth services.

The latest analysis from the Congressional Budget Office (CBO) exposes the stark reality behind proposed Medicaid cuts being pushed by Republican lawmakers. These cuts, aimed at offsetting the $4.5 trillion cost of extending Trump-era tax cuts (Weixel, 2025), would not only disrupt healthcare access for millions of low-income Americans, but they also jeopardize the future of telehealth—a vital service that has transformed care delivery, particularly for Medicaid recipients.

On March 3^rd, 2025, Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. published a policy statement directing the agency to no longer require standard federal regulatory rulemaking procedures for matters “relating to agency management or personnel or to public property, loans, grants, benefits, or contracts.” Notably, this gives the agency opportunity to forego issuing public comment opportunities for certain administrative actions. 

As the expiration deadline for telehealth flexibilities approaches, stakeholders across the healthcare landscape are grappling with critical questions: What happens next? How will regulatory shifts affect innovation, care delivery, and industry economics?

To answer these questions, we examine the issue through the lenses of five world-class experts from different fields—health policy, economics, technology, bioethics, and clinical care—offering insights that go beyond a single viewpoint.

The COVID-19 pandemic sparked a rapid transformation in healthcare delivery, accelerating the adoption of telehealth across the United States. While telehealth offered a lifeline to many patients during periods of restricted in-person care, concerns have emerged around equitable access and whether existing racial and ethnic disparities in healthcare have been exacerbated or alleviated by this digital shift.

A new study published in npj Digital Medicine (Fang et al., 2025) examines racial and ethnic disparities in telehealth utilization among Medicare beneficiaries. This large-scale analysis offers important insights for telehealth providers, digital health leaders, policymakers, and health equity advocates as they strive to design more inclusive and accessible digital health ecosystems.

Senator Steve Daines has introduced the "Telehealth Expansion Act of 2025," aiming to permanently allow High Deductible Health Plans (HDHPs) to cover telehealth services without requiring patients to meet their deductibles first. This change would amend the Internal Revenue Code of 1986, specifically modifying Section 223(c)(2) to ensure that HDHPs can offer first-dollar coverage for telehealth and remote care services without losing their status. The bill is set to take effect for plan years beginning after December 31, 2024.

This legislative move seeks to build upon temporary measures enacted during the COVID-19 pandemic, which allowed HDHPs to provide telehealth services without cost-sharing. By making this provision permanent, the bill aims to enhance access to remote healthcare services, offering patients more flexibility and potentially reducing overall healthcare costs.

The integration of telehealth services into standard healthcare offerings has been widely regarded as a positive development, especially in increasing access to care for individuals in rural or underserved areas. The "Telehealth Expansion Act of 2025" represents a significant step toward solidifying telehealth's role in the healthcare system, ensuring that patients with HDHPs can continue to benefit from remote care without financial barriers.

As artificial intelligence (AI) transforms the healthcare landscape, ensuring safety, transparency, and ethical use of AI-driven solutions has become a top priority. Recognizing the urgent need for oversight, URAC, a leader in healthcare accreditation, has launched an initiative to develop the nation’s first Health Care AI Accreditation Program—with CTeL as a key strategic partner.

The Center for Telehealth and e-Health Law (CTeL) has officially submitted its comment letter to the Drug Enforcement Administration (DEA) in response to Docket No. DEA-948 - Expansion of Buprenorphine Treatment via Telemedicine Encounter and Continuity of Care via Telemedicine for Veterans Affairs Patients. This rule represents a pivotal shift in how telemedicine can be leveraged to address opioid use disorder (OUD) treatment, and CTeL is committed to ensuring that telehealth remains an accessible and effective tool for patients and providers.

The U.S. healthcare system is facing an alarming crisis: a severe shortage of hospital staff, particularly nurses. According to the American Association of Colleges of Nursing (AACN), the demand for registered nurses (RNs) is projected to grow by 6% from 2022 to 2032, yet the supply remains insufficient. The COVID-19 pandemic only exacerbated the issue, leading to widespread burnout, early retirements, and a wave of career departures. Meanwhile, restrictive policies and outdated regulations hinder hospitals from deploying innovative solutions to address the crisis.

This staffing shortfall impacts patient care quality, hospital efficiency, and the well-being of existing healthcare professionals. But two key tangible solutions stand out: expanding virtual nursing education and cutting unnecessary bureaucratic red tape to enable workforce mobility and innovation.

The Center for Telehealth and e-Health Law (CTeL) proudly honors Dr. Andrew Taylor, Director of Artificial Intelligence for the Department of Emergency Medicine at Yale School of Medicine, with the 2025 Tr-AI-lblazer Award.

Dr. Taylor is recognized for his groundbreaking work in AI-driven healthcare, advancing clinical decision support, emergency care efficiency, and health equity. His innovations in machine learning, predictive analytics, and large language models have led to major breakthroughs, including real-time sepsis detection, opioid use disorder surveillance, and AI-assisted dementia recognition.

This award celebrates Dr. Taylor’s leadership in ensuring AI remains ethical, transparent, and transformative in improving patient outcomes.

Heart disease remains the leading cause of death in the U.S., yet early detection and timely intervention can save countless lives. Every 33 seconds, someone dies from heart disease, and nearly 68% of heart failure patients go undiagnosed in primary care settings.

Advanced remote monitoring technologies like Eko Health’s Sensora AI platform are changing this reality.

Through strategic partnerships, such as the collaboration between Eko Health and CTeL, healthcare providers are leveraging AI-powered tools to detect conditions like valvular heart disease, atrial fibrillation, and low ejection fraction—before symptoms become life-threatening.

Studies show that remote patient monitoring significantly improves outcomes, especially in underserved communities where cardiovascular disease often goes undiagnosed.

Access to these life-saving innovations should not be limited by outdated policies or reimbursement barriers. As the healthcare industry advances, policymakers must support innovation by ensuring reimbursement structures encourage adoption, not restrict it.

Miss Fern’s story (https://vimeo.com/1021153175) is a testament to what’s possible: diagnosed early with life-threatening valve disease, she received timely intervention and now has the same life expectancy as someone without the condition. Without access to Sensora’s real-time AI analysis, her condition could have gone unnoticed until it was too late.

Now is the time to push for policies that expand access to AI-driven diagnostic tools, remove barriers to innovation, and support equitable healthcare solutions. The future of cardiac care depends on it.